Celularity Inc. Warrant
N/A
USD
N/A
N/A
...
Chart
Financials
Description
CELUW Company Description
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases.
CELUW Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view CELUW Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of CELUW by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CELUW's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of CELUW in WallStreetBets Daily Discussion
CELUW News
Recent insights relating to CELUW
CNBC Recommendations
Recent picks made for CELUW stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in CELUW
Corporate Flights
Flights by private jets registered to CELUW
Our Analysis